You can buy or sell Mylan and other stocks, options, ETFs, and crypto commission-free!
Mylan N.V. Ordinary Shares, also called Mylan, is a pharmaceutical healthcare company. Read More The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
52 Week High
52 Week Low
Mylan N.V. Stock Quote (U.S.: Nasdaq)
Breaking Mylan NV reported smaller profit than expected in the fourth quarter and predicted earnings for 2019 would be substantially lower than analysts' projections Tuesday, pushing shares down more than 6% in late trading. The pharmaceutical giant reported fourth-quarter earnings of $51.2 million, or 10 cents a share, on sales of $3.08 billion, down from $3.24 billion a year ago. After taking out restructuring charges and other costs, the company claimed adjusted earnings of $1.30 a share, down from $1.4...
Current Trend: Mylan N.V. (NASDAQ: MYL)
Mylan N.V. is part of the healthcare sector and trades as part of the drug manufacturers industry. The company CEO is Heather Bresch. Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter OTC products in a variety of dosage forms and therapeutic categories. Previous Intraday Trading Performance: The MYL stock showed a previous change of 0.32% with an open at 28.09 and a close of 28.18. It reached an intraday high of 28.5...
Expected May 8, Pre-Market